Jaguar Health, Inc. (JAGX)
0.603
-0.05
(-7.91%)
USD |
NASDAQ |
Mar 05, 14:54
Jaguar Health Research and Development Expense (Annual) : 16.54M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Plus Therapeutics, Inc. | 10.58M |
| Geron Corp. | 71.43M |
| Corvus Pharmaceuticals, Inc. | 19.38M |
| Rapt Therapeutics, Inc. | 107.22M |
| Recursion Pharmaceuticals, Inc. | 425.27M |